The Patent Finder

Terms ending in 2031

Sanofi

Every in-force patent on Sanofi's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,234,025Extracellular Allosteric Inhibitor Binding Domain from a Tyrosine Kinase Receptor
In force
 · High confidence
Sanofi, Vib VZW, Life Sciences Research Partners VZW and Vrije Universiteit BrusselIn forceHigh confidence
US 8,748,436Carboxylic Acid Derivatives Having a 2,5,7-Substituted Oxazolopyrimidine Ring
In force
 · High confidence
SanofiIn forceHigh confidence
US 8,785,4392,5,7-Substituted Oxazolopyrimidine Derivatives
In force
 · High confidence
SanofiIn forceHigh confidence
US D748,253Cap for a Medicament Injection Device
In force
 · High confidence
Sanofi and Regeneron Pharmaceuticals, Inc.In forceHigh confidence
US 8,697,353Immunization Compositions and Methods
In force
 · High confidence
Sanofi Pasteur S.A.In forceHigh confidence
US 10,143,741Immunization Compositions and Methods
In force
 · Medium confidence
Sanofi Pasteur S.A.In forceMedium confidence
US 11,267,891FC Variant Antibodies and Their Uses
In force
 · High confidence
SanofiIn forceHigh confidence
US D782,033Medicament Injection Device
In force
 · High confidence
Sanofi and Regeneron Pharmaceuticals, Inc.In forceHigh confidence
US D782,035Injection Device
In force
 · High confidence
Sanofi S.A.In forceHigh confidence
US 9,040,5442,5-Substituted Oxazolopyrimidine Derivatives
In force
 · High confidence
SanofiIn forceHigh confidence
51 more term ends in 2031 · Pro
10 of 61 patents shown. Soonest term end first, then patent number.
Pro members see all 61.
Upgrade to Pro
58 of these are in force and held by Sanofi.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited